Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
10/2003
10/22/2003EP1353897A1 Method for producing dtpa monoamides
10/22/2003EP1353895A2 Primary intermediates for oxidative coloration of hair
10/22/2003EP1353662A2 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
10/22/2003EP1353638A1 Novel couplers for use in oxidative hair dyeing
10/22/2003EP1353637A1 Novel couplers for use in oxidative hair dyeing
10/22/2003EP1353636A1 Novel couplers for use in oxidative hair dyeing
10/22/2003EP1149076B1 O-thiocarbamoyl-aminoalkanol compounds, their pharmaceutically acceptable salts and process for preparing the same
10/22/2003EP1140803B1 ((aminoiminomethyl) amino) alkanecarboxamides and their applications in therapy
10/22/2003EP1140745B1 Colchinol derivatives as vascular damaging agents
10/22/2003EP1066022B1 Compositions for oxidation dyeing keratin fibres comprising a cationic coupler, novel cationic couplers, their use for oxidation dyeing and dyeing methods
10/22/2003CN1450999A Novel piperazine derivatives
10/22/2003CN1450991A Hydroxamate derives useful as deacetylase inhibitors
10/22/2003CN1450989A 7-substituted tetracycline compounds
10/22/2003CN1450049A N-arylating method using amino-acid as additives
10/22/2003CN1125058C Crystalline dibentothiazepine derivatives and its use as antipsychotic agent
10/22/2003CN1125044C Novel prostaglandin synthase inhibitors
10/21/2003US6635786 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (ADP-ribose) glycohydrolase, and methods for their use
10/21/2003US6635621 Alpha amino acid amide derivatives; reducing cathepsins B, L, S and/or K activity
10/21/2003CA2310318C Pseudopolymorphic forms of 2-[2-[4-[bis (4-fluorophenyl) methyl]-1-piperazinyl] ethoxy]acetic acid dihydrochloride
10/21/2003CA2153979C Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents
10/21/2003CA2098020C Anti-viral compounds
10/21/2003CA2060326C Antiarrhythmic tertiary amine-alkenyl-phenyl-alkanesulfonamides
10/16/2003WO2003084943A2 Terphenyl derivatives, preparation thereof, compositions containing same
10/16/2003WO2003084942A2 Stereoselective alkylation of chiral 2-methyl-4-protected piperazines
10/16/2003WO2003084941A2 Hydroxamic acid derivatives
10/16/2003WO2003084927A1 Haloalkenes, process for production thereof, and pest controllers containing the same
10/16/2003WO2003084922A1 Acyl-4-carboxyphenylurea derivatives, method for production and use thereof
10/16/2003WO2003084917A1 (2-((2-alkoxy) -phenyl) -cyclopent-1-enyl) aromatic carbo and heterocyclic acid and derivatives
10/16/2003WO2003084916A2 Compounds that modulate ppar activity and methods for their preparation
10/16/2003WO2003084542A1 Neurotrophic factor production accelerator
10/16/2003WO2003084541A1 Carboximide derivatives as useful uro-selective alpha-1a adrenoceptor blockers
10/16/2003WO2003084511A1 Palatable chewable tablet
10/16/2003WO2003048108A3 Compounds for treatment of inflammation, diabetes and related disorders
10/16/2003WO2003037271A3 Compounds, pharmaceutical compositions and methods of use therefor
10/16/2003WO2002100849A3 Novel nitriles useful as reversible inhibitors of cysteine proteases
10/16/2003WO2001066534A3 Cyclic and bicyclic diamino histamine-3 receptor antagonists
10/16/2003US20030195362 For therapy of retroviral infection and in particular an HIV infection
10/16/2003US20030195356 4-Aryl-1-(indanmethyl dihydrobenzofuranmethyl or dihydrobenzothiophenemethyl) piperidines tetrahydropyridines or piperazines
10/16/2003US20030195353 Novel process for the synthesis of 5-(4-fluorophenyl)-1-[2-((2R,4R)-4-hydroxy-6-oxo- tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide
10/16/2003US20030195229 Administering viricides such as N-nonenyl glucosamine, and optionally with mixtures of nucleosides, nucleotides, immunomodulators or immunostimulants for prophylaxis viral diseases
10/16/2003US20030195226 Nitrogen compounds such as pyridine-3-carbaldehyde, O-(((4-undecyloxy-phenyl)amino)carbonyl)oxime, used for prophylaxis of vision, eating or cardiovascular disorders, and as anxiolytic and antiemetic agents
10/16/2003US20030195219 Hybrid 2-aminotetralin and aryl-substituted piperazine compounds and their use in altering cns activity
10/16/2003US20030195174 Novel 4-dedimethylaminotetracycline derivatives
10/16/2003US20030195173 Colchinol derivatives as angiogenesis inhibitors
10/16/2003US20030195159 HIV protease inhibitors based on amino acid derivatives
10/16/2003US20030195110 Remaining donor atoms of the ligand are selected from the group consisting of C, N, P, As, O, S, and Se
10/16/2003US20030192132 (P-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds
10/16/2003CA2481970A1 Neurotrophic factor production accelerator
10/16/2003CA2481879A1 Hydroxamic acid derivatives
10/16/2003CA2481817A1 Acyl-4-carboxyphenylurea derivatives, method for production and use thereof
10/16/2003CA2481392A1 Terphenyl derivatives, preparation thereof, compositions containing same
10/16/2003CA2481035A1 (2-((2-alkoxy) -phenyl) -cyclopent-1-enyl) aromatic carbo and heterocyclic acid and derivatives
10/16/2003CA2481025A1 Palatable chewable tablet
10/16/2003CA2480481A1 Stereoselective alkylation of chiral 2-methyl-4-protected piperazines
10/15/2003EP1351975A2 C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases
10/15/2003EP1351959A1 Novel pleuromutilin derivatives
10/15/2003EP1351946A2 Materials and methods to potentiate cancer treatment
10/15/2003EP1351938A1 Phenyl derivatives
10/15/2003EP1351936A1 Aryl piperidine and piperazine derivatives as inducers of ldl-receptor expression
10/15/2003EP1351933A1 Il-8 receptor antagonists
10/15/2003EP1351928A2 Novel n(phenylsulphonyl)glycine derivatives and their therapeutic use
10/15/2003EP1351924A2 Diamines as modulators of chemokine receptor activity
10/15/2003EP0766674B1 New hiv protease inhibitors
10/15/2003CN1449391A N-(3,5-dichloro-2-methoxyphenyl)-4-methoxy-3-piperazin-1-yl-benzenesulfonamide
10/15/2003CN1449382A Polyarylcarboxamides useful as lipid lowering agents
10/15/2003CN1449273A Antimicotic nail varnish composition
10/15/2003CN1124270C Cyclopentene derivatives useful as antagonists of the motilin receptor
10/15/2003CN1124255C Inhibition of matrix metalloproteases by substituted phenethyl compounds
10/14/2003US6632963 Bicyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof
10/14/2003US6632840 Monoacyl-substituted guanidines, a process for their preparation, their use as a medicament or diagnostic aid, and pharmaceutical compositions containing them
10/14/2003US6632838 Use of bissulfonamides for producing medicines for the treatment of hyperlipidemia
10/14/2003US6632834 Compositions and methods for treating conditions responsive to estrogen
10/14/2003US6632816 Aromatic derivatives as HIV aspartyl protease inhibitors
10/14/2003US6632810 Cyclic diamine compound with condensed-ring groups
10/14/2003CA2286750C Application and production process of a group of anticancer compounds
10/14/2003CA2122911C 1,3-substituted cycloalkenes and cycloalkanes as central nervous system agents
10/09/2003WO2003082928A1 Control agents for living-type free radical polymerization and methods of polymerizing
10/09/2003WO2003082842A1 Piperazinyl- or piperidinylamine-sulfamic acid amides as inhibitors of steroid sulfatase
10/09/2003WO2003082825A1 Use of an alfa2-adrenoreceptor antagonist for cns-related diseases
10/09/2003WO2003082814A1 Purified lasofoxifene and a method for purification of racemic lasofoxifene by recrystallization
10/09/2003WO2003082809A1 Diaminoacid-aminoacid-polyamine based gemini surfactant compounds
10/09/2003WO2003082808A1 Benzamide derivatives
10/09/2003WO2003082288A1 Carbamic acid compounds comprising a piperazine linkage as hdac inhibitors
10/09/2003WO2003082268A2 Hemiasterlin derivatives and uses thereof in the treatment of cancer
10/09/2003WO2003082263A1 Sulfamic acids as inhibitors of human cytoplasmic protein tyrosine phosphatases
10/09/2003WO2003082260A2 Tuberculosis treatment using pleuromutilin derivatives
10/09/2003WO2003082205A2 Compounds and methods
10/09/2003WO2002009686A3 Cdc25 phosphatase inhibitors
10/09/2003WO2001079189A3 'amides of r-2-(aminoaryl)-propionic acids for use in theprevention of leucocyte activation'
10/09/2003US20030191324 A N,O-bis(diphenylphosphino)-2-azetidine derivatives, a transition metal complex for use as hydrogenation catalysts
10/09/2003US20030191317 Sulfonyl aryl or heteroaryl hydroxamic acid compounds
10/09/2003US20030191153 Antithrombotic amides
10/09/2003US20030191145 Unsaturated derivatives at the 4-position of 6-tert-butyl-1,1-dimethylindane and their use in human and veterinary medicine and in cosmetics
10/09/2003US20030191136 Melanin concentrating hormone receptor ligands
10/09/2003US20030191135 Serotonergic agents with long-acting in vivo effects
10/09/2003US20030191118 Inhibitors of alpha4 mediated cell adhesion
10/09/2003US20030191117 Acyclic piperazine and piperidine derivatives
10/09/2003US20030191027 Herbicides
10/09/2003CA2480686A1 Piperazinyl- or piperidinylamine-sulfamic acid amides as inhibitors of steroid sulfatase
10/09/2003CA2479764A1 Hemiasterlin derivatives and uses thereof
1 ... 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 ... 341